CTSH Q2 2025 Earnings
Reported Jul 30, 2025 at 4:03 PM ET · SEC Source
Q2 25 EPS
$1.31
BEAT +3.99%
Est. $1.26
Q2 25 Revenue
$5.25B
BEAT +1.07%
Est. $5.19B
vs S&P Since Q2 25
-57.2%
TRAILING MARKET
CTSH -41.2% vs S&P +16.0%
Market Reaction
Did CTSH Beat Earnings? Q2 2025 Results
Cognizant posted a clean beat across the board in Q2 2025, with revenue of $5.25 billion growing 8.1% year-over-year and adjusted diluted EPS of $1.31 clearing the $1.26 consensus estimate by roughly 4%, as the IT services giant continued to benefit … Read more Cognizant posted a clean beat across the board in Q2 2025, with revenue of $5.25 billion growing 8.1% year-over-year and adjusted diluted EPS of $1.31 clearing the $1.26 consensus estimate by roughly 4%, as the IT services giant continued to benefit from its acquisition of engineering firm Belcan, which contributed approximately 400 basis points to headline growth. Bookings were the quarter's standout signal, with trailing twelve-month bookings reaching $27.80 billion on a 1.4x book-to-bill ratio, underpinned by two new contracts each exceeding $1.00 billion in total contract value. Adjusted operating margin held at 15.6%, expanding 40 basis points year-over-year, while the company accelerated share repurchases to $368.00 million in the quarter and lifted its full-year shareholder return target to $2.00 billion from $1.70 billion. Looking ahead, management guided Q3 revenue to $5.27 to $5.35 billion, though a one-time non-cash tax charge of approximately $400.00 million tied to the One Big Beautiful Bill Act is expected to weigh heavily on reported GAAP EPS next quarter; the company also faces a pending $380 million lawsuit from Clorox tied to a 2023 cybersecurity incident. Full-year adjusted EPS guidance stands at $5.08 to $5.22.
Key Takeaways
- • Belcan acquisition contributed approximately 400 basis points to year-over-year revenue growth
- • Fourth consecutive quarter of organic year-over-year revenue growth
- • Record trailing 12-month bookings of $27.8 billion with 1.4x book-to-bill
- • Two mega deals with TCV over $1 billion each in Q2
- • Investments in talent, platforms and AI infrastructure
- • Blended utilization excluding trainees at 85%
CTSH YoY Financials
Q2 2025 vs Q2 2024, source: SEC Filings
CTSH Revenue by Segment
With YoY comparisons, source: SEC Filings
CTSH Revenue by Geography
With YoY comparisons, source: SEC Filings
“Our second quarter revenue performance exceeded the high end of our guidance range, underscoring the effectiveness of our strategy to build a resilient and durable portfolio that positions us to win in the AI era.”
— Ravi Kumar S, Q2 2025 Earnings Press Release
CTSH Earnings Trends
CTSH vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
CTSH EPS Trend
Earnings per share: estimate vs actual
CTSH Revenue Trend
Quarterly revenue: estimate vs actual
CTSH Quarterly Results
4 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q1 26 BEAT | $1.33 | $1.40 | +4.99% | $5.41B | +0.01% |
| Q4 25 BEAT FY | $1.32 | $1.35 | +2.02% | $5.33B | +0.41% |
| FY Full Year | — | $5.28 | — | $21.11B | — |
| Q3 25 BEAT | $1.30 | $1.39 | +6.73% | $5.42B | +1.83% |
| Q2 25 BEAT | $1.26 | $1.31 | +3.99% | $5.25B | +1.07% |